Bazarbachi A, Galimard JE, Dalle IA, Socie G, et al. Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP. Am J Hematol 2025 May 30. doi: 10.1002/ajh.27726.
PMID: 40445901